Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data

References

• ManninoDMHomaDMAkinbamiLJFordESReddSCChronic obstructive pulmonary disease surveillance – United States, 1971–2000Respir Care2002471184119912354338
   PubMedGoogle Scholar
• ShavelleRMPaculdoDRKushSJManninoDMStraussDJLife expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up StudyInt J Chron Obstruct Pulmon Dis2009413714819436692
   PubMedGoogle Scholar
• US Burden of Disease CollaboratorsThe state of US health, 1990–2010: burden of diseases, injuries, and risk factorsJAMA201331059160823842577
   PubMed Web of Science ®Google Scholar
• Burden of COPD [webpage on the Internet]GenevaWorld Health Organization (WHO) Available from: http://www.who.int/respiratory/copd/burden/en/index.htmlAccessed February 11, 2014
   Google Scholar
• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med20063e44217132052
   PubMed Web of Science ®Google Scholar
• QaseemASnowVShekellePDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of PhysiciansAnn Intern Med200714763363817975186
   PubMed Web of Science ®Google Scholar
• MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: new insights in current and ex-smokersRespir Med20071011305131217112715
   PubMed Web of Science ®Google Scholar
• SpencerSCalverleyPMBurgePSJonesPWImpact of preventing exacerbations on deterioration of health status in COPDEur Respir J20042369870215176682
   PubMed Web of Science ®Google Scholar
• BakerCLZouKHSuJRisk assessment of readmissions following an initial COPD-related hospitalizationInt J Chron Obstruct Pulmon Dis2013855155924348031
   PubMed Web of Science ®Google Scholar
• ElixhauserAAAuDHPodulkaJReadmission for Chronic Obstructive Pulmonary Disease, 2008Rockville, MDHCUP Statistical Brief #121: Healthcare Cost and Utilization Project2008
   Google Scholar
• National Quality ForumMeasure 1891: Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Chronic Obstructive Pulmonary Disease (COPD) HospitalizationWashington, DCThe National Quality Forum2012 Available from: http://www.qualityforum.org/Projects/n-r/Pulmonary_Endorsement_Maintenance/1891_30_Day_RSRR_COPD.aspxAccessed February 11, 2014
   Google Scholar
• JencksSFWilliamsMVColemanEARehospitalizations among patients in the Medicare fee-for-service programN Engl J Med20093601418142819339721
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality [homepage on the Internet]Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS)Washington, DCUS Department of Health and Human Services [updated February 18, 2014]. Available from: http://hcupnet.ahrq.gov/HCUPnet.jsp?Id=226284BF0BAE1506&Form=SelLAY&JS=Y&Action=%3E%3ENext%3E%3E&_LAY=ResearcherAccessed February 11, 2014
   Google Scholar
• Garcia-AymerichJBarreiroEFarreroEMarradesRMMoreraJAntóJMPatients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study)Eur Respir J2000161037104211292102
   PubMed Web of Science ®Google Scholar
• PereraPNArmstrongEPSherrillDLSkrepnekGHAcute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortalityCOPD2012913114122409371
   PubMedGoogle Scholar
• StrasselsSASmithDHSullivanSDMahajanPSThe costs of treating COPD in the United StatesChest200111934435211171708
   PubMed Web of Science ®Google Scholar
• IngebrigtsenTSMarottJLVestboJCharacteristics of undertreatment in COPD in the general populationChest20131441811181823989916
   PubMed Web of Science ®Google Scholar
• global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease [homepage on the Internet]Global Initiative for Chronic Obstructive Lung Disease2014 Available from: http://www.goldcopd.comAccessed February 11, 2014
   Google Scholar
• KewKMMavergamesCWaltersJALong-acting beta-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201310CD01017724127118
   PubMed Web of Science ®Google Scholar
• Databases and Online Tools [webpage on the Internet]Ann Arbor, MITruven Health Analytics Inc.2014 Available from: http://www.truvenhealth.com/your_healthcare_focus/pharmaceutical_and_medical_device/data_databases_and_online_tools.aspxAccessed February 11, 2014
   Google Scholar
• CaoZZouKHBakerCLRespiratory-related medical expenditure and inpatient utilisation among COPD patients receiving long-acting bronchodilator therapyJ Med Econ20111414715821288057
   PubMedGoogle Scholar
• Centers for Disease Control and PreventionClassification of Diseases, Functioning, and Disability [webpage on the Internet]International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM)Hyattsville, MDNational Center for Health Statistics2013 Available from: http://www.cdc.gov/nchs/icd/icd9cm.htmAccessed Febrary 11, 2014
   Google Scholar
• DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol1992456136191607900
   PubMed Web of Science ®Google Scholar
• FagerlandMWLydersenSLaakePThe McNemar test for binary matched-pairs data: mid-p and asymptotic are better than exact conditionalBMC Med Res Methodol2013139123848987
   PubMed Web of Science ®Google Scholar
• BatemanEDTashkinDSiafakasNA one-year trial of tiotropium Respimat plus usual therapy in COPD patientsRespir Med20101041460147220620037
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med20113641093110321428765
   PubMed Web of Science ®Google Scholar
• WedzichaJADecramerMFickerJHAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med2013119920924429126
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet200737078679617765528
   PubMed Web of Science ®Google Scholar
• WilkinsonTMDonaldsonGCHurstJRSeemungalTAWedzichaJAEarly therapy improves outcomes of exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20041691298130314990395
   PubMed Web of Science ®Google Scholar
• DalalAAShahMBD’SouzaAODhamaneADCraterGDOutcomes associated with timing of maintenance treatment for COPD exacerbationAm J Manag Care201218e338e34523009332
   PubMed Web of Science ®Google Scholar
• NantsupawatTLimsuwatCNugentKFactors affecting chronic obstructive pulmonary disease early rehospitalizationChron Respir Dis20129939822399574
   PubMed Web of Science ®Google Scholar
• YipNHYuenGLazarEJAnalysis of hospitalizations for COPD exacerbation: opportunities for improving careCOPD20107859220397808
   PubMedGoogle Scholar
• MakeBDutroMPPaulose-RamRMartonJPMapelDWUndertreatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
   PubMed Web of Science ®Google Scholar
• Trigueros CarreroJAHow should we define and classify exacerbations in chronic obstructive pulmonary disease?Expert Rev Respir Med20137334123551022
   PubMed Web of Science ®Google Scholar
• AlmagroPBarreiroBOchoa de EchaguenARisk factors for hospital readmission in patients with chronic obstructive pulmonary diseaseRespiration20067331131716155352
   PubMed Web of Science ®Google Scholar
• BahadoriKFitzGeraldJMRisk factors of hospitalization and readmission of patients with COPD exacerbation – systematic reviewInt J Chron Obstruct Pulmon Dis2007224125118229562
   PubMedGoogle Scholar